Metabolic pharmacology of anthelmintic drugs targeting mitochondrial fumarate reductase in neurocysticercosis.

Vinaud MC, Bezerra JCB

Open source

DOI
10.1080/03602532.2026.2724981
Published
2026 Sep 3
Container
Drug metabolism reviews
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/03602532.2026.2724981,
  title = {Metabolic pharmacology of anthelmintic drugs targeting mitochondrial fumarate reductase in neurocysticercosis.},
  author = {Vinaud MC and Bezerra JCB},
  year = {2026},
  journal = {Drug metabolism reviews},
  doi = {10.1080/03602532.2026.2724981},
  url = {https://doi.org/10.1080/03602532.2026.2724981}
}

RIS

TY  - JOUR
TI  - Metabolic pharmacology of anthelmintic drugs targeting mitochondrial fumarate reductase in neurocysticercosis.
AU  - Vinaud MC
AU  - Bezerra JCB
PY  - 2026
JO  - Drug metabolism reviews
DO  - 10.1080/03602532.2026.2724981
UR  - https://doi.org/10.1080/03602532.2026.2724981
ER  - 

APA

MC, V., & JCB, B. (2026). Metabolic pharmacology of anthelmintic drugs targeting mitochondrial fumarate reductase in neurocysticercosis.. Drug metabolism reviews. https://doi.org/10.1080/03602532.2026.2724981

Source records